Typical and atypical antipsychotics differentially modulates D2/5-HT2A heterooligomer signaling

被引：0
|
作者：
Gomez-Garcia, Laura [1 ]
Gomez, Sonia [1 ]
Isabel Cadavid, Maria [1 ]
Manuel Brea, Jose [1 ]
Isabel Loza, Maria [1 ]
机构：
[1] Univ Santiago de Compostela, Grp Biofarma, Santiago De Compostela, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2019年 / 125卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P036
引用
收藏
页码：44 / 45
页数：2
相关论文
共 50 条
  • [21] 5-HT2A and 5-HT2C receptors and their atypical regulation properties
    Van Oekelen, D
    Luyten, WHML
    Leysen, JE
    LIFE SCIENCES, 2003, 72 (22) : 2429 - 2449
  • [22] Typical and atypical antipsychotics do not differ markedly in their reversibility of antagonism of the dopamine D2 receptor
    Sahlholm, Kristoffer
    Marcellino, Daniel
    Nilsson, Johanna
    Ogren, Sven Ove
    Fuxe, Kjell
    Arhem, Peter
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 (01): : 149 - 155
  • [23] Different effects of the 5-HT2A receptor agonist DOI and the 5-HT2A receptor antagonist altanserin on D2 receptor binding in the rat brain
    Nikolaus, S.
    Wittsack, H.
    Beu, M.
    Antke, C.
    Hautzel, H.
    Mori, Y.
    Mamlins, E.
    Antoch, G.
    Mueller, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S635 - S635
  • [24] Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT1A receptors but not 5-HT2A receptors
    Bortolozzi, Analia
    Masana, Merce
    Diaz-Mataix, Llorenc
    Cortes, Roser
    Cecilia Scorza, Maria
    Gingrich, Jay A.
    Toth, Miklos
    Artigas, Francesc
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (10): : 1299 - 1314
  • [25] Atypical antipsychotics, tardive dyskinesia, and D2 receptors
    Duggal, Harpreet S.
    Mendhekar, Dattatreya Namdeorao
    AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (08): : 1449 - 1450
  • [26] Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain
    I. Kusumi
    Y. Takahashi
    K. Suzuki
    K. Kameda
    T. Koyama
    Journal of Neural Transmission, 2000, 107 : 295 - 302
  • [27] Conformationally constrained butyrophenones with mixed dopaminergic (D2) and serotoninergic (5-HT2A, 5-HT2C) affinities:: Synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics
    Raviña, E
    Negreira, J
    Cid, J
    Masaguer, CP
    Rosa, E
    Rivas, ME
    Fontenla, JA
    Loza, MI
    Tristán, H
    Cadavid, MI
    Sanz, F
    Lozoya, E
    Carotti, A
    Carrieri, A
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (15) : 2774 - 2797
  • [28] Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain
    Kusumi, I
    Takahashi, Y
    Suzuki, K
    Kameda, K
    Koyama, T
    JOURNAL OF NEURAL TRANSMISSION, 2000, 107 (03) : 295 - 302
  • [29] Conformationally restricted butyrophenones with mixed dopaminergic (D2) and serotoninergic (5-HT2A) affinities.: Synthesis of 5-aminoethyl- and 6-aminomethyl-4-oxotetrahydroindoles as potential atypical antipsychotics
    Masaguer, CF
    Casariego, I
    Raviña, E
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1999, 47 (05) : 621 - 632
  • [30] Abaperidone hydrochloride.: Antipsychotic, dopamine D2 antagonist, 5-HT2A antagonist
    Bolós, J
    Príncep, M
    Guglietta, A
    DRUGS OF THE FUTURE, 2001, 26 (04) : 335 - 341
12345